GGrantIndex
← Leaderboards

Linmarie Sikich

University Of North Carolina Chapel Hill

$18,880,212
Attributed
$18,880,212
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.9M · FY200521
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$18,880,212 · 10

By mechanism

U01$13,047,588 · 2
P50$2,437,800 · 1
R01$1,538,976 · 1
K23$861,131 · 1
R34$680,908 · 1
U54$290,380 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Child

Research focus

ChildResponseRandomizedSymptomsPharmaceutical PreparationsPlacebosBaseParticipantEnrollmentAdultFutureClinical TrialsBrainSiteDoseSchizophreniaAntipsychotic AgentsPrimary OutcomeDouble-Blind MethodBehavior TherapyAutism Spectrum DisorderBehavioralCommunicationAdverse Effects

Grant awards (31)

Impact of combined medication and behavioral treatment in young children with comorbid ASD and ADHD$505,914
P50 · FY2021 · HD · contact PI
Impact of combined medication and behavioral treatment in young children with comorbid ASD and ADHD$508,453
P50 · FY2020 · HD · contact PI
Impact of combined medication and behavioral treatment in young children with comorbid ASD and ADHD$471,357
P50 · FY2019 · HD · contact PI
Impact of combined medication and behavioral treatment in young children with comorbid ASD and ADHD$475,076
P50 · FY2018 · HD · contact PI
Impact of combined medication and behavioral treatment in young children with comorbid ASD and ADHD$477,000
P50 · FY2017 · HD · contact PI
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)$1,708,646
U01 · FY2016 · HD · contact PI
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)$2,028,182
U01 · FY2015 · HD · contact PI
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)$439,500
U01 · FY2015 · HD · contact PI
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)$2,562,872
U01 · FY2014 · HD · contact PI
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)$2,435,695
U01 · FY2013 · HD · contact PI
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)$2,589,347
U01 · FY2012 · HD · contact PI
2/3-Improving Metabolic Parameters of Antipsychotic Child Treatment$276,172
R01 · FY2012 · MH · contact PI
2/3-Improving Metabolic Parameters of Antipsychotic Child Treatment$321,759
R01 · FY2011 · MH · contact PI
Intensive Brain Training in Early Onset Schizophrenia & Schizoaffective Disorder$334,409
R34 · FY2010 · MH · contact PI
2/3-Improving Metabolic Parameters of Antipsychotic Child Treatment$90,647
R01 · FY2010 · MH · contact PI
MITOCHONDRIAL LOCALIZATION OF PROTEINS CONTAINING COILED COIL-HELIX DOMAINS$22,510
P20 · FY2010 · RR · contact PI
2/3-Improving Metabolic Parameters of Antipsychotic Child Treatment$423,301
R01 · FY2009 · MH · contact PI
Intensive Brain Training in Early Onset Schizophrenia & Schizoaffective Disorder$346,499
R34 · FY2009 · MH · contact PI
2/3-Improving Metabolic Parameters of Antipsychotic Child Treatment$427,097
R01 · FY2008 · MH · contact PI
CLINICAL TRIAL: METFORMIN MITIGATION OF ANTIPSYCHOTIC-INDUCED METABOLIC DYSREGUL$536
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PEDIATRIC PHARMACOKINETIC AND TOLERABILITY STUDY OF LITHIUM FOR$383
M01 · FY2008 · RR · contact PI
Treatment of Psychotic Disorders in Youth$172,225
K23 · FY2006 · MH · contact PI
TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS)$77,615
U01 · FY2006 · MH · contact PI
TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS)$13,140
U01 · FY2006 · MH · contact PI
TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS)$483,079
U01 · FY2005 · MH
Treatment of Psychotic Disorders in Youth$172,226
K23 · FY2005 · MH
TREATMENT OF EARLY ONSET SCHIZOPHRENIA SPECTRUM (TEOSS)$709,512
U01 · FY2004 · MH
Treatment of Psychotic Disorders in Youth$172,227
K23 · FY2004 · MH
Treatment of Psychotic Disorders in Youth$172,226
K23 · FY2003 · MH
TREATMENT PROJECT$290,380
U54 · FY2002 · MH
Treatment of Psychotic Disorders in Youth$172,227
K23 · FY2002 · MH